OECI-EACR precision medicine for cancer: Conference report 1-4 March 2015, Luxembourg

Anna Golebiewska ¹, Sabrina Fritah ¹, Maria Romina Girotti ²

Affiliations

¹ NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H), Luxembourg, L-1526 Luxembourg.
² Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, M20 4BX, UK.

PMID: 25932043
40 References

Abstract

The 'Precision Medicine for Cancer' was the first meeting of a new series of conferences organised biannually by the European Association for Cancer Research (EACR) and the Organisation for European Cancer Institutes (OECI). The main objective of the meeting was to focus on novel topics in precision medicine by allowing strong interactions between participants and to access the speakers easily. As the first implementations of personalised medicine are appreciated in the clinic, the aim of the meeting was to further educate both researchers and clinicians and learn more from the novel approaches in the field. Similarly, the interaction between two organisations-the research-oriented EACR and the clinic-oriented OECI-was of a great value for the meeting. This OECI-EACR 2015 report will highlight the major findings of this outstanding meeting.

Keywords: OECI-EACR 2015; cancer; conference report; personalised medicine; precision medicine.

Other Links

Free PMC article
Full text on Ecancermedicalscience

References

References
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Peter Eirew, Adi Steif, +43 authors, Samuel Aparicio. less Nature, 2014 Dec 04; 518(7539). PMID: 25470049 Free PMC article. Highly Cited.
Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Zachary T Schug, Barrie Peck, +30 authors, Eyal Gottlieb. less Cancer Cell, 2015 Jan 15; 27(1). PMID: 25584894 Free PMC article. Highly Cited.
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Anna Golebiewska, Sébastien Bougnaud, +7 authors, Simone P Niclou. less Brain, 2013 Mar 06; 136(Pt 5). PMID: 23460667 Free PMC article.
Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer. Sandra Misale, Sabrina Arena, +14 authors, Alberto Bardelli. less Sci Transl Med, 2014 Feb 21; 6(224). PMID: 24553387 Highly Cited.
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. Lawrence N Kwong, James C Costello, +13 authors, Lynda Chin. less Nat Med, 2012 Sep 18; 18(10). PMID: 22983396 Free PMC article. Highly Cited.
Next-generation sequencing of disseminated tumor cells. Elen K Møller, Parveen Kumar, +12 authors, Vessela N Kristensen. less Front Oncol, 2014 Jan 16; 3. PMID: 24427740 Free PMC article.
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Volker Hovestadt, David T W Jones, +42 authors, Peter Lichter. less Nature, 2014 May 23; 510(7506). PMID: 24847876 Highly Cited.
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. Fei Su, Amaya Viros, +50 authors, Richard Marais. less N Engl J Med, 2012 Jan 20; 366(3). PMID: 22256804 Free PMC article. Highly Cited.
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response. Mathew J Garnett, Ultan McDermott. Curr Opin Genet Dev, 2014 Mar 13; 24. PMID: 24607840 Free PMC article. Review.
Mutations of the BRAF gene in human cancer. Helen Davies, Graham R Bignell, +49 authors, P Andrew Futreal. less Nature, 2002 Jun 18; 417(6892). PMID: 12068308 Highly Cited.
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma. Maria Romina Girotti, Filipa Lopes, +25 authors, Caroline Springer. less Cancer Cell, 2014 Dec 17; 27(1). PMID: 25500121 Free PMC article. Highly Cited.
A new genome-driven integrated classification of breast cancer and its implications. Sarah-Jane Dawson, Oscar M Rueda, Samuel Aparicio, Carlos Caldas. EMBO J, 2013 Feb 12; 32(5). PMID: 23395906 Free PMC article. Highly Cited. Review.
Molecular insights into pediatric brain tumors have the potential to transform therapy. Amar Gajjar, Stefan M Pfister, Michael D Taylor, Richard J Gilbertson. Clin Cancer Res, 2014 Nov 16; 20(22). PMID: 25398846 Free PMC article. Review.
Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer. Alessio Amatu, Andrea Sartore-Bianchi, +9 authors, Salvatore Siena. less Clin Cancer Res, 2013 Feb 21; 19(8). PMID: 23422094
The multitude of molecular analyses in cancer: the opening of Pandora’s box. Hege G Russnes, Per E Lønning, Anne-Lise Børresen-Dale, Ole C Lingjærde. Genome Biol, 2014 Oct 16; 15(9). PMID: 25316146 Free PMC article.
Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Muhammad Zaeem Noman, Bassam Janji, +8 authors, Salem Chouaib. less Cancer Res, 2011 Aug 04; 71(18). PMID: 21810913
Genome-driven integrated classification of breast cancer validated in over 7,500 samples. H Raza Ali, Oscar M Rueda, +4 authors, Carlos Caldas. less Genome Biol, 2014 Aug 29; 15(8). PMID: 25164602 Free PMC article. Highly Cited.
Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes. Daniel Stieber, Anna Golebiewska, +10 authors, Simone P Niclou. less Acta Neuropathol, 2013 Oct 25; 127(2). PMID: 24154962 Free PMC article.
Critical appraisal of the side population assay in stem cell and cancer stem cell research. Anna Golebiewska, Nicolaas H C Brons, Rolf Bjerkvig, Simone P Niclou. Cell Stem Cell, 2011 Feb 08; 8(2). PMID: 21295271 Highly Cited.
CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Sami Ventelä, Eleonora Sittig, +8 authors, Jukka Westermarck. less Oncotarget, 2014 Dec 05; 6(1). PMID: 25474139 Free PMC article.
No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients. Maria Romina Girotti, Grazia Saturno, Paul Lorigan, Richard Marais. Mol Oncol, 2014 Sep 03; 8(6). PMID: 25178978 Free PMC article. Review.
Parallel in vivo and in vitro melanoma RNAi dropout screens reveal synthetic lethality between hypoxia and DNA damage response inhibition. Patricia A Possik, Judith Müller, +14 authors, Daniel S Peeper. less Cell Rep, 2014 Dec 03; 9(4). PMID: 25456132
The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. Adi F Gazdar, Trisha K Savage, +9 authors, Elisabeth Brambilla. less J Thorac Oncol, 2015 Feb 13; 10(4). PMID: 25675280 Free PMC article.
Stromal cell-induced miRNA alteration in chronic lymphocytic leukemia: how a minute and unavoidable cell contamination impairs miRNA profiling. J Paggetti, G Berchem, E Moussay. Leukemia, 2013 Feb 15; 27(8). PMID: 23407459
Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis. Elodie Viry, Joanna Baginska, +4 authors, Bassam Janji. less Autophagy, 2013 Nov 20; 10(1). PMID: 24248158 Free PMC article.
Signatures of mutational processes in human cancer. Ludmil B Alexandrov, Serena Nik-Zainal, +72 authors, Michael R Stratton. less Nature, 2013 Aug 16; 500(7463). PMID: 23945592 Free PMC article. Highly Cited.
A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition. F Javier Carmona, Veronica Davalos, +19 authors, Manel Esteller. less Cancer Res, 2014 Aug 12; 74(19). PMID: 25106427
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Christina Curtis, Sohrab P Shah, +29 authors, Samuel Aparicio. less Nature, 2012 Apr 24; 486(7403). PMID: 22522925 Free PMC article. Highly Cited.
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma. Maria R Girotti, Malin Pedersen, +12 authors, Richard Marais. less Cancer Discov, 2012 Dec 18; 3(2). PMID: 23242808 Free PMC article. Highly Cited.
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Sandra Misale, Rona Yaeger, +23 authors, Alberto Bardelli. less Nature, 2012 Jun 23; 486(7404). PMID: 22722830 Free PMC article. Highly Cited.
MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Etienne Moussay, Kai Wang, +8 authors, David J Galas. less Proc Natl Acad Sci U S A, 2011 Apr 05; 108(16). PMID: 21460253 Free PMC article.
Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution. Sandra Misale, Federica Di Nicolantonio, +2 authors, Alberto Bardelli. less Cancer Discov, 2014 Oct 09; 4(11). PMID: 25293556 Highly Cited. Review.
Principles and methods of integrative genomic analyses in cancer. Vessela N Kristensen, Ole Christian Lingjærde, +3 authors, Anne-Lise Børresen-Dale. less Nat Rev Cancer, 2014 Apr 25; 14(5). PMID: 24759209 Highly Cited. Review.
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Cassandra L Hodgkinson, Christopher J Morrow, +23 authors, Caroline Dive. less Nat Med, 2014 Jun 02; 20(8). PMID: 24880617 Highly Cited.
BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer. Olafur A Stefansson, Alberto Villanueva, +2 authors, August Vidal, Lola Martí, Manel Esteller. less Epigenetics, 2012 Oct 17; 7(11). PMID: 23069641 Free PMC article.
RNA helicase A is a downstream mediator of KIF1Bβ tumor-suppressor function in neuroblastoma. Zhi Xiong Chen, Karin Wallis, +10 authors, Susanne Schlisio. less Cancer Discov, 2014 Jan 29; 4(4). PMID: 24469107
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Sonja J Heidorn, Carla Milagre, +8 authors, Richard Marais. less Cell, 2010 Feb 10; 140(2). PMID: 20141835 Free PMC article. Highly Cited.
Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target. Anchit Khanna, John E Pimanda, Jukka Westermarck. Cancer Res, 2013 Nov 10; 73(22). PMID: 24204027 Highly Cited. Review.
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling. Berta Sanchez-Laorden, Amaya Viros, +12 authors, Richard Marais. less Sci Signal, 2014 Mar 29; 7(318). PMID: 24667377
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981 Free PMC article. Highly Cited.

BioKDE: Biomedical Knowledge Discovery Engine

Abstract

Other Links